רווח למניה בשנים עשר החודשים האחרונים: Elanco Animal Health Incorporated (ELAN)

The launch of innovative antiparasitic products is restoring margins despite the debt load. Elanco Animal Health (ELAN) operates across the global animal health market, serving both B2B and B2C segments. Customer loyalty and pet care ensure sustainable demand. The company's net income per share over 12 months confirms this foundation, with the current mark equal to -0.30.

The dynamics of this multiple allow for an assessment of the real efficiency of profit generation per share of capital, excluding the impact of the total emission volume. By analyzing the net income per share over the last 12 months, an investor can see the ability of Elanco Animal Health (ELAN) to monetize regulatory advantages and customer loyalty within the veterinary sector, which directly determines the asset's market value.